PHILADELPHIA
- Arthur H. Rubenstein, MBBCh, an accomplished physician,
diabetes researcher and academic leader, has been named
executive vice president of the University of Pennsylvania
for the Health System and dean of the School of Medicine.
In this role, he will lead the University of Pennsylvania
Health System, widely recognized as one of the top academic
health systems in the country. As executive vice president,
he will report to Judith Rodin, president of the University
of Pennsylvania, and as dean, to Robert Barchi, provost.
Robert Martin, Health System CEO, will report to Rubenstein.
"Arthur Rubenstein is an exceptional educator and
an accomplished physician, scientist and leader who
possesses the experience and skills necessary to lead
Penn's Health System into the future," said President
Rodin. " We are absolutely delighted about his
decision to come to Penn."
Rubenstein, 63, has served for the past four years as
dean and Gustave L. Levy Distinguished Professor at
Mount Sinai School of Medicine in New York. He is known
at Mount Sinai for recruiting and retaining outstanding
faculty, developing and implementing a comprehensive
strategic planning process and for significant increases
in federally funded research. He was on the faculty
of the University of Chicago from 1967 to 1997, serving
as chairman of Chicago's Department of Medicine starting
in 1981.
An internationally prominent endocrinologist, recognized
for clinical expertise and groundbreaking research in
diabetes, as well as for inspired teaching, he has been
a member of the Institute of Medicine since 1985 and
is a fellow of the American Association for the Advancement
of Science and the American Academy of Arts & Sciences
and has led the Association of American Physicians,
the American Board of Internal Medicine, and the Association
of Professors of Medicine.
Author of more than 350 publications, Dr. Rubenstein
has held editorial advisory positions with numerous
respected journals, including service on the editorial
boards of the Annals of Internal Medicine, Journal of
Diabetes and Its Complications, Medicine and Clinical
Trials Advisor. He was also a consulting editor to the
Journal of Clinical Investigation.
"With his years of experience and a keen appreciation
for the challenges facing today's academic heath systems,
we believe Dr. Rubenstein will lead Penn to even greater
prominence in academic medicine," said Provost
Barchi. "He is committed to closely coordinating
the medical school's education and research mission
with the clinical care offered by Penn's specialists,
primary care doctors and other health-care providers,"
he said.
Rubenstein received his medical degree from the University
of the Witwatersrand in Johannesburg in 1960. He was
affiliated with that institution and the Johannesburg
General Hospital while in South Africa and subsequently,
with the Hammersmith Hospital in London.
"This is a critical time for Penn's Health System,"
said Rodin. "With the many financial challenges
confronting America's medical schools and teaching hospitals,
we face the future with a great sense of pride in what
we have accomplished and with the expectation of growing
momentum," she said.
Dwight L. Evans, M.D., chairman and professor of psychiatry
at Penn, chaired the search committee for the executive
vice president/dean position.
"On behalf of the search committee, I can say we
are absolutely delighted that President Rodin has successfully
recruited Arthur Rubenstein to be our new executive
vice president/dean. Dr. Rubenstein is among the most
highly respected and admired leaders in academic medicine
today. I believe he will be received with great enthusiasm
throughout the School of Medicine, Health System, and
the University," said Dr. Evans.
As the nation's first medical school, founded in 1765,
Penn's School of Medicine currently ranks second in
total funding from the NIH, often considered one of
the most reliable barometers of research strength. It
is ranked among the top five medical schools in the
nation by U.S. News & World Report. In addition
to the School of Medicine, the University of Pennsylvania
Health System also includes the Clinical Practices of
the University of Pennsylvania, a faculty practice plan
comprising more than 940 specialists; the Hospital of
the University of Pennsylvania, Pennsylvania Hospital,
Presbyterian Medical Center, and Phoenixville Hospital;
more than 230 physicians in Penn's primary-care network;
a hospice; home care; a nursing home; and multispecialty
satellite facilities.
# # #
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.